annual CFI:
-$7.51B-$13.10B(-234.18%)Summary
- As of today (August 23, 2025), NVS annual cash flow from investing activities is -$7.51 billion, with the most recent change of -$13.10 billion (-234.18%) on December 31, 2024.
- During the last 3 years, NVS annual CFI has fallen by -$11.72 billion (-278.44%).
- NVS annual CFI is now -234.18% below its all-time high of $5.60 billion, reached on December 31, 2023.
Performance
NVS Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$2.26B-$2.59B(-785.63%)Summary
- As of today (August 23, 2025), NVS quarterly cash flow from investing activities is -$2.26 billion, with the most recent change of -$2.59 billion (-785.63%) on June 30, 2025.
- Over the past year, NVS quarterly CFI has increased by +$944.43 million (+29.45%).
- NVS quarterly CFI is now -121.25% below its all-time high of $10.65 billion, reached on March 31, 2023.
Performance
NVS quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$5.34B+$944.43M(+15.03%)Summary
- As of today (August 23, 2025), NVS TTM cash flow from investing activities is -$5.34 billion, with the most recent change of +$944.43 million (+15.03%) on June 30, 2025.
- Over the past year, NVS TTM CFI has increased by +$2.74 billion (+33.90%).
- NVS TTM CFI is now -140.12% below its all-time high of $13.31 billion, reached on June 30, 2023.
Performance
NVS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
NVS Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -234.2% | +29.4% | +33.9% |
| 3 y3 years | -278.4% | +80.5% | -600.0% |
| 5 y5 years | -237.3% | -432.4% | +60.9% |
NVS Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -234.2% | at low | -121.3% | +80.5% | -140.1% | +33.9% |
| 5 y | 5-year | -234.2% | +43.0% | -121.3% | +80.5% | -140.1% | +60.9% |
| alltime | all time | -234.2% | +52.0% | -121.3% | +82.8% | -140.1% | +74.0% |
NVS Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$2.26B(-785.6%) | -$5.34B(-15.0%) |
| Mar 2025 | - | $330.00M(-110.9%) | -$6.28B(-16.4%) |
| Dec 2024 | -$7.51B(-234.2%) | -$3.03B(+711.0%) | -$7.51B(+34.4%) |
| Sep 2024 | - | -$374.00M(-88.3%) | -$5.59B(-30.8%) |
| Jun 2024 | - | -$3.21B(+256.7%) | -$8.08B(+36.0%) |
| Mar 2024 | - | -$899.00M(-19.2%) | -$5.94B(-205.9%) |
| Dec 2023 | $5.60B(+281.2%) | -$1.11B(-61.1%) | $5.61B(+6.8%) |
| Sep 2023 | - | -$2.86B(+167.8%) | $5.25B(-60.5%) |
| Jun 2023 | - | -$1.07B(-110.0%) | $13.31B(+384.2%) |
| Mar 2023 | - | $10.65B(-825.7%) | $2.75B(+87.2%) |
| Dec 2022 | $1.47B(-65.1%) | -$1.47B(-128.2%) | $1.47B(-80.4%) |
| Sep 2022 | - | $5.20B(-144.7%) | $7.50B(+602.1%) |
| Jun 2022 | - | -$11.63B(-224.2%) | $1.07B(-91.7%) |
| Mar 2022 | - | $9.37B(+105.2%) | $12.79B(+204.0%) |
| Dec 2021 | $4.21B(-131.9%) | $4.56B(-470.4%) | $4.21B(-554.4%) |
| Sep 2021 | - | -$1.23B(-1370.1%) | -$926.00M(-46.8%) |
| Jun 2021 | - | $97.00M(-87.6%) | -$1.74B(-23.1%) |
| Mar 2021 | - | $780.00M(-236.6%) | -$2.26B(-82.8%) |
| Dec 2020 | -$13.18B(+492.2%) | -$571.00M(-72.1%) | -$13.18B(+7.2%) |
| Sep 2020 | - | -$2.04B(+381.2%) | -$12.29B(-9.9%) |
| Jun 2020 | - | -$425.00M(-95.8%) | -$13.65B(+3.4%) |
| Mar 2020 | - | -$10.14B(-3289.0%) | -$13.20B(+492.8%) |
| Dec 2019 | -$2.23B(-60.2%) | $318.00M(-109.4%) | -$2.23B(-70.2%) |
| Sep 2019 | - | -$3.40B(<-9900.0%) | -$7.48B(+50.6%) |
| Jun 2019 | - | $25.00M(-97.0%) | -$4.97B(+644.7%) |
| Mar 2019 | - | $829.00M(-116.8%) | -$667.00M(-88.1%) |
| Dec 2018 | -$5.59B(+77.6%) | -$4.93B(+457.0%) | -$5.59B(+232.6%) |
| Sep 2018 | - | -$886.00M(-120.5%) | -$1.68B(+13.6%) |
| Jun 2018 | - | $4.33B(-205.6%) | -$1.48B(-75.9%) |
| Mar 2018 | - | -$4.09B(+299.5%) | -$6.14B(+95.1%) |
| Dec 2017 | -$3.15B(-8.5%) | -$1.02B(+49.6%) | -$3.15B(-1.5%) |
| Sep 2017 | - | -$685.00M(+103.3%) | -$3.20B(-2.1%) |
| Jun 2017 | - | -$337.00M(-69.4%) | -$3.26B(-13.4%) |
| Mar 2017 | - | -$1.10B(+2.6%) | -$3.77B(+9.6%) |
| Dec 2016 | -$3.44B(-68.1%) | -$1.07B(+42.7%) | -$3.44B(-15.2%) |
| Sep 2016 | - | -$752.00M(-10.9%) | -$4.06B(-0.0%) |
| Jun 2016 | - | -$844.00M(+9.3%) | -$4.06B(-18.8%) |
| Mar 2016 | - | -$772.00M(-54.3%) | -$5.00B(-53.6%) |
| Dec 2015 | -$10.78B(-1324.1%) | -$1.69B(+124.4%) | -$10.78B(+7.7%) |
| Sep 2015 | - | -$753.00M(-57.8%) | -$10.01B(+8.4%) |
| Jun 2015 | - | -$1.78B(-72.8%) | -$9.24B(+7.7%) |
| Mar 2015 | - | -$6.56B(+613.5%) | -$8.57B(-1072.9%) |
| Dec 2014 | $881.00M(-126.3%) | -$919.00M(-3846.1%) | $881.00M(-203.0%) |
| Sep 2014 | - | $24.53M(-102.2%) | -$855.00M(-47.6%) |
| Jun 2014 | - | -$1.12B(-138.7%) | -$1.63B(+41.2%) |
| Mar 2014 | - | $2.90B(-209.1%) | -$1.16B(-65.5%) |
| Dec 2013 | -$3.35B | -$2.65B(+252.6%) | -$3.35B(+2.3%) |
| Sep 2013 | - | -$753.00M(+17.0%) | -$3.28B(-27.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2013 | - | -$643.51M(-192.0%) | -$4.49B(-1.3%) |
| Mar 2013 | - | $699.51M(-127.1%) | -$4.55B(-19.8%) |
| Dec 2012 | -$5.67B(+624.1%) | -$2.58B(+30.8%) | -$5.67B(+45.1%) |
| Sep 2012 | - | -$1.97B(+180.8%) | -$3.91B(+54.6%) |
| Jun 2012 | - | -$702.32M(+66.5%) | -$2.53B(+46.5%) |
| Mar 2012 | - | -$421.77M(-48.3%) | -$1.73B(+120.3%) |
| Dec 2011 | -$783.77M(-95.0%) | -$815.94M(+38.3%) | -$783.77M(+23.4%) |
| Sep 2011 | - | -$589.85M(-683.8%) | -$635.15M(-94.0%) |
| Jun 2011 | - | $101.04M(-80.6%) | -$10.60B(-24.1%) |
| Mar 2011 | - | $520.97M(-178.1%) | -$13.97B(-10.6%) |
| Dec 2010 | -$15.63B(+10.3%) | -$667.31M(-93.7%) | -$15.63B(-18.5%) |
| Sep 2010 | - | -$10.56B(+222.8%) | -$19.17B(+47.5%) |
| Jun 2010 | - | -$3.27B(+187.9%) | -$13.00B(+4.3%) |
| Mar 2010 | - | -$1.14B(-73.0%) | -$12.46B(-12.0%) |
| Dec 2009 | -$14.16B(+35.3%) | -$4.21B(-3.8%) | -$14.16B(+20.0%) |
| Sep 2009 | - | -$4.38B(+60.4%) | -$11.80B(-42.5%) |
| Jun 2009 | - | -$2.73B(-3.9%) | -$20.54B(+23.0%) |
| Mar 2009 | - | -$2.84B(+53.7%) | -$16.70B(+59.5%) |
| Dec 2008 | -$10.47B(-872.8%) | -$1.85B(-85.9%) | -$10.47B(+21.5%) |
| Sep 2008 | - | -$13.12B(-1281.1%) | -$8.62B(-554.4%) |
| Jun 2008 | - | $1.11B(-67.2%) | $1.90B(+2880.4%) |
| Mar 2008 | - | $3.38B(-230.3%) | $63.67M(-101.4%) |
| Dec 2007 | $1.35B(-123.0%) | - | - |
| Sep 2007 | - | -$2.60B(+259.1%) | -$4.56B(+144.0%) |
| Jun 2007 | - | -$723.27M(-41.8%) | -$1.87B(-68.9%) |
| Mar 2007 | - | -$1.24B(-1401.9%) | -$6.01B(-8.1%) |
| Dec 2006 | -$5.90B(-19.9%) | - | - |
| Sep 2006 | - | $95.42M(-102.0%) | -$6.54B(-34.2%) |
| Jun 2006 | - | -$4.87B(+985.7%) | -$9.95B(-4.8%) |
| Mar 2006 | - | -$448.22M(-66.2%) | -$10.45B(+38.8%) |
| Dec 2005 | -$7.37B(+130.5%) | -$1.32B(-60.0%) | -$7.53B(+27.1%) |
| Sep 2005 | - | -$3.31B(-38.3%) | -$5.93B(+41.7%) |
| Jun 2005 | - | -$5.37B(-317.1%) | -$4.18B(-775.7%) |
| Mar 2005 | - | $2.47B(+787.6%) | $619.13M(-119.4%) |
| Dec 2004 | -$3.20B(+148.3%) | $278.48M(-117.8%) | -$3.20B(-8.0%) |
| Sep 2004 | - | -$1.57B(+178.7%) | -$3.48B(+82.2%) |
| Jun 2004 | - | -$562.73M(-58.2%) | -$1.91B(+41.8%) |
| Mar 2004 | - | -$1.35B(+42.3%) | -$1.35B(+42.3%) |
| Dec 2003 | -$1.29B(-55.0%) | - | - |
| Dec 2002 | -$2.86B(+3.4%) | -$945.86M | -$945.86M |
| Dec 2001 | -$2.77B(+2066.0%) | - | - |
| Dec 2000 | -$127.83M(-93.6%) | - | - |
| Dec 1999 | -$2.01B(+122.4%) | - | - |
| Dec 1998 | -$901.92M(-50.0%) | - | - |
| Dec 1997 | -$1.80B(-1036.6%) | - | - |
| Dec 1996 | $192.61M(-108.3%) | - | - |
| Dec 1995 | -$2.32B(-58.8%) | - | - |
| Dec 1994 | -$5.64B(+166.0%) | - | - |
| Dec 1993 | -$2.12B | - | - |
FAQ
- What is Novartis AG annual cash flow from investing activities?
- What is the all time high annual CFI for Novartis AG?
- What is Novartis AG annual CFI year-on-year change?
- What is Novartis AG quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Novartis AG?
- What is Novartis AG quarterly CFI year-on-year change?
- What is Novartis AG TTM cash flow from investing activities?
- What is the all time high TTM CFI for Novartis AG?
- What is Novartis AG TTM CFI year-on-year change?
What is Novartis AG annual cash flow from investing activities?
The current annual CFI of NVS is -$7.51B
What is the all time high annual CFI for Novartis AG?
Novartis AG all-time high annual cash flow from investing activities is $5.60B
What is Novartis AG annual CFI year-on-year change?
Over the past year, NVS annual cash flow from investing activities has changed by -$13.10B (-234.18%)
What is Novartis AG quarterly cash flow from investing activities?
The current quarterly CFI of NVS is -$2.26B
What is the all time high quarterly CFI for Novartis AG?
Novartis AG all-time high quarterly cash flow from investing activities is $10.65B
What is Novartis AG quarterly CFI year-on-year change?
Over the past year, NVS quarterly cash flow from investing activities has changed by +$944.43M (+29.45%)
What is Novartis AG TTM cash flow from investing activities?
The current TTM CFI of NVS is -$5.34B
What is the all time high TTM CFI for Novartis AG?
Novartis AG all-time high TTM cash flow from investing activities is $13.31B
What is Novartis AG TTM CFI year-on-year change?
Over the past year, NVS TTM cash flow from investing activities has changed by +$2.74B (+33.90%)